Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone

Author： Cataldo N.A. Abbasi F. McLaughlin T.L. Lamendola C. Reaven G.M.

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.76, Iss.5, 2001-11, pp. : 1057-1059

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

By Ghazeeri G. Kutteh W.H. Bryer-Ash M. Haas D. Ke R.W.

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 562-566

Elsevier

Access to resources Recommend Favorite

Insulin resistance and polycystic ovary syndrome

By Bernard L. Christin-Maitre S. Basille C. Chabbert-Buffet N.

Gynecology Obstetrique & Fertilite, Vol. 31, Iss. 2, 2003-02 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Insulin Resistance and Polycystic Ovary Syndrome

By Bhathena R. K.

Journal of Obstetrics & Gynaecology, Vol. 28, Iss. 4, 2008-05 ,pp. : 465-466

Informa Healthcare

Access to resources Recommend Favorite

Comparing rosiglitazone with ethinylestradiol/cyproterone acetate in the treatment of polycystic ovary syndrome

By Pesant Marie-Hélène Baillargeon Jean-Patrice

Expert Review of Obstretrics and Gynecology, Vol. 1, Iss. 1, 2006-09 ,pp. : 81-92

Informa Healthcare

Access to resources Recommend Favorite

Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome

By Fruzzetti F. Bersi C. Parrini D. Ricci C. Genazzani A.R.

Fertility and Sterility, Vol. 77, Iss. 5, 2002-05 ,pp. : 936-944

Elsevier

Access to resources Recommend Favorite